Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Suisse (CSUI) EBIT (2016 - 2026)

Cannabis Suisse (CSUI) has disclosed EBIT for 10 consecutive years, with -$74980.0 as the latest value for Q4 2025.

  • Quarterly EBIT rose 18.77% to -$74980.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$280380.0 through Nov 2025, up 10.35% year-over-year, with the annual reading at -$288013.0 for FY2025, 12.09% down from the prior year.
  • EBIT for Q4 2025 was -$74980.0 at Cannabis Suisse, up from -$84535.0 in the prior quarter.
  • The five-year high for EBIT was $58494.0 in Q1 2021, with the low at -$674966.0 in Q2 2021.
  • Average EBIT over 5 years is -$91038.7, with a median of -$62968.5 recorded in 2023.
  • Peak annual rise in EBIT hit 189.71% in 2021, while the deepest fall reached 4666.71% in 2021.
  • Over 5 years, EBIT stood at -$41351.0 in 2021, then rose by 28.96% to -$29375.0 in 2022, then plummeted by 72.6% to -$50702.0 in 2023, then crashed by 82.06% to -$92309.0 in 2024, then rose by 18.77% to -$74980.0 in 2025.
  • According to Business Quant data, EBIT over the past three periods came in at -$74980.0, -$84535.0, and -$54077.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.